Prospective two center study of CD38 bright CD8+ effector memory T-cells as a predictor of acute GVHD.
Khandelwal, P; Chaturvedi, V; Owsley, E; Efebera, YA; Choe, H; Bostic, M; Kumchala, P; Rajgolikar, G; Ranganathan, P; Garzon, R; et al.
Transplantation Reports.
2022;
7.
Quercetin ameliorates XIAP deficiency-associated hyperinflammation.
Chiang, SC C; Owsley, E; Panchal, N; Chaturvedi, V; Terrell, CE; Jordan, MB; Mehta, PA; Davies, SM; Akeno, N; Booth, C; et al.
Blood.
2022;
140:706-715.
HLH: birds of a feather flock together.
Jordan, MB.
Blood.
2022;
140:167-168.
P1203: THE OPTIMIZED HLH INFLAMMATORY (OHI) INDEX IDENTIFIES LYMPHOMA PATIENTS WITH UNEXPECTEDLY HIGH MORTALITY NOT RELATED TO DISEASE PROGRESSION.
Zoref-Lorenz, A; Murakami, J; Hofstetter, L; Abadi, U; Iyer, S; Mohamed, S; Miller, PG; Natour, AE H; Weinstein, S; Yacobovich, J; et al.
HemaSphere.
2022;
6:1089-1090.
Consensus-Based Guidelines for the Recognition, Diagnosis, and Management of Hemophagocytic Lymphohistiocytosis in Critically Ill Children and Adults.
Hines, MR; Von Bahr Greenwood, T; Beutel, G; Beutel, K; Hays, JA; Horne, A; Janka, G; Jordan, MB; Van Laar, JA M; Lachmann, G; et al.
Critical Care Medicine.
2022;
50:860-872.
Emapalumab in primary haemophagocytic lymphohistiocytosis and the pathogenic role of interferon gamma: A pharmacometric model-based approach.
Jacqmin, P; Laveille, C; Snoeck, E; Jordan, MB; Locatelli, F; Ballabio, M; de Min, C.
British Journal of Clinical Pharmacology.
2022;
88:2128-2139.
A Case of Chronic Lymphocytic Leukemia Complicated by Hemophagocytic Lymphohistiocytosis: Identifying the Aberrant Immune Response.
Zoref-Lorenz, A; Yuklea, M; Topaz, G; Jordan, MB; Ellis, M.
Journal of General Internal Medicine.
2022;
37:1542-1546.
Malignancy-associated haemophagocytic lymphohistiocytosis.
Setiadi, A; Zoref-Lorenz, A; Lee, CY; Jordan, MB; Chen, LY C.
The Lancet Haematology.
2022;
9:e217-e227.
An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis.
Zoref-Lorenz, A; Murakami, J; Hofstetter, L; Iyer, S; Alotaibi, AS; Mohamed, SF; Miller, PG; Guber, E; Weinstein, S; Yacobovich, J; et al.
Blood.
2022;
139:1098-1110.
High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia.
Davila Saldana, BJ; John, T; Bonifant, C; Buchbinder, D; Chandra, S; Chandrakasan, S; Chang, W; Chen, L; Elfassy, HL; Geerlinks, AV; et al.
Blood Advances.
2022;
6:452-459.